Many vaccines are only partially effective, have waning efficacy, or do not work well in the very young or the very old. For more than a decade, Ofer Levy, MD, Ph.D., and David Dowling, Ph.D., in the Precision Vaccines Program ...
Jul 3, 2024
0
30
A new way to map the spread and evolution of pathogens, and their responses to vaccines and antibiotics, will provide key insights to help predict and prevent future outbreaks. The approach combines a pathogen's genomic data ...
Jul 3, 2024
0
4
Since the outset of the COVID-19 pandemic, 10 to 30% of the general population has experienced some form of virus-induced cognitive impairment, including trouble concentrating, brain fog or memory loss. This led a team of ...
Jun 27, 2024
0
48
In the first 10 months of availability, COVID-19 vaccines prevented around 235,000 deaths and 1.6 million hospitalizations in the U.S. However, by April 2023, 19% of Americans still hadn't received their first vaccine dose ...
Jun 27, 2024
0
23
Tuberculosis is still one of the deadliest infectious diseases, causing over one million deaths each year worldwide. Additionally, about one-fourth of the world's population carries Mycobacterium tuberculosis without showing ...
Jun 19, 2024
0
10
In a critical global public health development, a candidate vaccine for tuberculosis (TB) has been created using a gene-editing approach.
Jun 19, 2024
0
29
Researchers from the Institut d'Investigació en Atenció Primària Jordi Gol (IDIAPJGol) and the Barcelona Institute for Global Health (ISGlobal) have led a study on the effectiveness of vaccines against COVID-19 among cancer ...
Jun 19, 2024
0
49
In just a few months, hospitals and health systems nationwide will start working to vaccinate as many staff as possible against the flu. And a new study published in the journal JAMA Network Open suggests that more of those ...
Jun 13, 2024
0
40
If you've been sick with COVID-19, you may have some protection against certain versions of the common cold.
Jun 12, 2024
0
50
A team from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) and Monash University has engineered a COVID-19 vaccine that induced—in pre-clinical models—very long-lasting, protective ...
Jun 4, 2024
0
111
